Home Cart Sign in  
Chemical Structure| 374913-63-0 Chemical Structure| 374913-63-0

Structure of Madrasin
CAS No.: 374913-63-0

Chemical Structure| 374913-63-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Madrasin is a potent and cell penetrant splicing inhibitor that interferes with the early stages of spliceosome assembly.

Synonyms: DDD00107587

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Madrasin

CAS No. :374913-63-0
Formula : C16H17N5O2
M.W : 311.34
SMILES Code : O=C1NC(NC2=NC(C)=C3C=CC(OC)=CC3=N2)=NC(C)=C1C
Synonyms :
DDD00107587
MDL No. :MFCD02233199
InChI Key :QQJIYKXTEMDJFM-UHFFFAOYSA-N
Pubchem ID :135444382

Safety of Madrasin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Madrasin

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 20–30 μM 4 hours Madrasin treatment led to the formation of cytoplasmic granules containing mRNAs, which included G3BP1 and TIA1 but lacked typical SG proteins such as eIF3b, eIF4B, and RPS6. PMC11109975
U2OS cells 20–30 μM 4 hours Madrasin treatment led to the formation of cytoplasmic granules containing mRNAs, which included G3BP1 and TIA1 but lacked typical SG proteins such as eIF3b, eIF4B, and RPS6. PMC11109975
MDA-MB-231 cells 30 uM 24 hours Inhibition of pre-mRNA splicing, leading to down-regulation of POLR2A at both RNA and protein levels. PMC6735682
293T cells 30 uM 24 hours Inhibition of pre-mRNA splicing, leading to down-regulation of POLR2A at both RNA and protein levels. PMC6735682
HeLa cells 30 uM 24 hours Inhibition of pre-mRNA splicing, leading to down-regulation of POLR2A at both RNA and protein levels. PMC6735682
HEK293 cells 10, 20, 30 µM 4, 8, 24 hours To investigate the effect of Madrasin on the splicing of multiple pre-mRNAs in HEK293 cells. Results showed that Madrasin significantly inhibited the splicing of RIOK3 and BRD2 pre-mRNAs, but had minimal effect on the splicing of Hsp40 pre-mRNA. PMC4263873
HeLa cells 10, 20, 30 µM 4, 8, 24 hours To investigate the effect of Madrasin on the splicing of multiple pre-mRNAs in HeLa cells. Results showed that Madrasin significantly inhibited the splicing of RIOK3, HPV18 E6, and BRD2 pre-mRNAs, but had minimal effect on the splicing of Hsp40 pre-mRNA. PMC4263873

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.21mL

0.64mL

0.32mL

16.06mL

3.21mL

1.61mL

32.12mL

6.42mL

3.21mL

References

 

Historical Records

Categories